Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small ...

Cathepsin G (CTSG) is overexpressed and aberrantly localized for antigen presentation on acute myeloid leukemia blasts and stem cells compared to normal hematopoietic progenitors. Earlier this year, ...